Zc3Hav1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Official Symbol: ZC3HAV1 [@guo2004]
Official Full Name: Zinc Finger CCCH-Type Antiviral Protein 1 [@zhu2011]
Location: Chromosome 7q34 [@todorova2022]
Gene ID: 92075
Zc3Hav1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Official Symbol: ZC3HAV1 [@guo2004]
Official Full Name: Zinc Finger CCCH-Type Antiviral Protein 1 [@zhu2011]
Location: Chromosome 7q34 [@todorova2022]
Gene ID: 92075
Overview
Zinc Finger CCCH-Type Antiviral Protein 1 (ZC3HAV1), also known as ZAP, is a host restriction factor that inhibits viral replication by degrading viral mRNAs and blocking viral gene expression. It plays an important role in the innate immune response to retroviruses, flaviviruses, and other viruses.
Gene Structure
The ZC3HAV1 gene spans approximately 48 kb and consists of 8 exons. It encodes a protein of 707 amino acids with multiple zinc finger domains.
Protein Structure
ZC3HAV1 contains:
CCCH-type zinc finger domains (4 domains) for RNA binding
WWE domain for protein-protein interactions
PARN-like domain with RNAse activity
Coactivator function
Molecular Function
ZC3HAV1 is an antiviral protein that specifically targets viral mRNAs for degradation:
RNA Binding: Recognizes specific sequences in viral mRNAs
mRNA Degradation: Recruits the RNA exosome to degrade target mRNAs
Translation Inhibition: Blocks viral protein synthesis
ZC3HAV1 is expressed in most tissues with highest expression in:
Immune cells (T cells, B cells, NK cells)
Liver
Brain ([neurons](/entities/neurons) and glia)
Constitutively expressed at low levels, inducible by interferon
Role in Neurodegeneration
Alzheimer's Disease
May be upregulated in response to viral infections in AD
Modulates neuroinflammation
Potential interaction with amyloid pathology
Parkinson's Disease
May affect viral susceptibility in PD
Modulates inflammatory responses
Potential therapeutic target
Neuroinflammation
Regulates type I interferon responses
Modulates microglial activation
Links antiviral immunity to neuroinflammation
Disease Associations
Therapeutic Implications
ZC3HAV1-based therapies:
Antiviral Approaches: Enhancing ZC3HAV1 function against neurotropic viruses
Immunomodulation: Modulating neuroinflammation
Combination Therapies: With antiviral drugs
Background
The study of Zc3Hav1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Molecular Mechanisms
RNA Binding Specificity
ZC3HAV1 (ZAP) recognizes viral RNA through specific sequence elements:
CpG dinucleotides: Enriched in viral genomes
ZAP-responsive elements (ZREs): Specific RNA sequences
Structure-dependent binding: Also recognizes RNA secondary structures